Skip to main content

Table 2 Distribution of Intraoperative, postoperative characteristic of the parturient who under want caesarean section at WSCSH in 2022. (n = 336)

From: Comparison of postoperative pain severity between primary and repeated cesarean section: a prospective cohort study

Intraoperative data

 

Group

P value

Repeated

Primipara

Bupivacaine dose

10 mg

2(25.0%)

6(75.0%)

0.356

12.5 mg

152(50.5%)

149(49.5%)

15 mg

14(51.9%)

13(48.1%)

Additive drug

Non

148(48.1%)

160(51.9%)

0.058

Dexamethasone

7(70.0%)

3(30.0%)

Morphine

13(76.5%)

5(23.5%)

Intraoperative analgesia used

Non

164(49.5%)

167(50.5%)

0.170

Tramadol

2(100.0%)

00.0%

Morphine

2(75%)

1(25%)

Intraoperative MAP

Mean ± SD

68.92 ± 7.98

71.28 ± 8.44

0.209

Intraoperative HR

Mean ± SD

81.47 ± 7.44

82.81 ± 8.14

0.116

Blood lose

Mean ± SD

519.82 ± 99.36

508.2 ± 103.3

0.296

Surgery duration

Mean ± SD

42.97 ± 10.17

39.38 ± 8.25

0.001**

Postoperative MAP

Mean ± SD

71.29 ± 5.87

72.27 ± 5.24

0.109

Postoperative HR

Mean ± SD

81.50 ± 6.58

80.82 ± 5.77

0.311

  1. Hint: The values are presented as frequency (proportion) and Mean ± Standard deviation, MAP Mean arterial pressure, HR Heart Rate
  2. ** highly statistically significant